$CYH Cashflow Statement | Understand Stock

$CYH

$2.66 -$0.18 (6.34%) Live

$CYH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization
Deferred income taxes
Stock-based compensation expense
Impairment and (gain) loss on sale of businesses, net
Gain from early extinguishment of debt
Gain on sale of equity interests in Macon Healthcare, LLC
Gain from CoreTrust Transaction
Other non-cash expenses, net

Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:
Patient accounts receivable
Supplies, prepaid expenses and other current assets
Repayment/derecognition of Medicare accelerated payments
Accounts payable, accrued liabilities and income taxes
Other

Net cash provided by operating activities
Cash flows from investing activities:
Acquisitions of facilities and other related businesses
Purchases of property and equipment
Proceeds from disposition of hospitals and other ancillary operations
Proceeds from sale of property and equipment
Purchases of available-for-sale debt securities and equity securities
Proceeds from sales of available-for-sale debt securities and equity securities
Purchases of investments in unconsolidated affiliates
Proceeds from sale of equity interests in Macon Healthcare, LLC
Distribution of CoreTrust Transaction proceeds
Increase in other investments
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Repurchase of restricted stock shares for payroll tax withholding requirements
Deferred financing costs and other debt-related costs
Proceeds from noncontrolling investors in joint ventures
Redemption of noncontrolling investments in joint ventures
Distributions to noncontrolling investors in joint ventures
Other borrowings
Issuance of long-term debt
Proceeds from ABL Facility
Repayments of long-term indebtedness
Net cash used in financing activities
Net change in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of cash flow information:
Interest payments
Income tax payments, net of refunds

Comments